TY  - GEN
AU  - Neri,Paola
AU  - Ren,Li
AU  - Gratton,Kathy
AU  - Stebner,Erin
AU  - Johnson,Jordan
AU  - Klimowicz,Alexander
AU  - Duggan,Peter
AU  - Tassone,Pierfrancesco
AU  - Mansoor,Adnan
AU  - Stewart,Douglas A
AU  - Lonial,Sagar
AU  - Boise,Lawrence H
AU  - Bahlis,Nizar J
TI  - Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors
SN  - 1528-0020
PY  - 2012///0214
KW  - Adult
KW  - Animals
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - BRCA1 Protein
KW  - genetics
KW  - Boronic Acids
KW  - Bortezomib
KW  - Cell Line, Tumor
KW  - Cells, Cultured
KW  - DNA Repair
KW  - drug effects
KW  - Enzyme Inhibitors
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Mice
KW  - Mice, SCID
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Proteasome Endopeptidase Complex
KW  - Proteasome Inhibitors
KW  - Pyrazines
KW  - RNA, Messenger
KW  - metabolism
KW  - Rad51 Recombinase
KW  - Survival Analysis
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2011-06-363911
ER  -